US sanctions, rising inflation and war damage are exacerbating the shortage of medicines in Iran, forcing some patients to reduce doses, postpone treatment or switch to cheaper and less effective drugs.

US sanctions, rising inflation and war damage are exacerbating the shortage of medicines in Iran, forcing some patients to reduce doses, postpone treatment or switch to cheaper and less effective drugs.

Nearly 800 drugs are reportedly affected, while pharmacies are also struggling as insurance companies owe them about $300 million.

Iran produces more than 97% of its drugs by volume, but many drugs and pharmaceutical ingredients are still dependent on imports and foreign exchange.

Experts say U.S. sanctions complicate payments and prevent foreign banks and suppliers from dealing with Iranian buyers, even though the drug itself is usually exempt.

The crisis was further exacerbated by US and Israeli airstrikes earlier this year, which Iranian officials said damaged more than 40 pharmaceutical companies, suppliers and distributors.

Source: CNN